Medical - Diagnostics & Research - Companies & Stock Screener

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

YoY Change

BillionToOne, Inc.

BLLN

Market Cap $4.84B

Dividends 0.0%

P/E Ratio 204.3

Revenue $108M +83.8%

Net Income $18M -550.6%

Profit Margin +16.6%

Employees 620

View Stock

Interpace Biosciences, Inc.

IDXG

Market Cap $46.18M

Dividends 0.0%

P/E Ratio 1.6

Revenue $9.03M -21.6%

Net Income $721k -56.2%

Profit Margin +8.0%

Employees 111

View Stock

HTG Molecular Diagnostics Inc

HTGM

Market Cap $1.06M

Dividends 0.0%

P/E Ratio 0.0

Revenue $1.03M -12.8%

Net Income -$5.05M -22.2%

Profit Margin -489.6%

Employees 53

View Stock

HTG Molecular Diagnostics, Inc.

HTGMQ

Market Cap $1.06M

Dividends 0.0%

P/E Ratio 0.0

Revenue $1.03M -12.8%

Net Income -$5.05M -22.2%

Profit Margin -489.6%

Employees 53

View Stock

Biocept Inc

BIOC

Market Cap $450.79K

Dividends 0.0%

P/E Ratio -0.0

Revenue $589k -94.4%

Net Income -$3.63M -32.8%

Profit Margin -616.5%

Employees 50

View Stock

Biocept, Inc.

BIOCQ

Market Cap $450.79K

Dividends 0.0%

P/E Ratio -0.0

Revenue $589k -94.4%

Net Income -$3.63M -32.8%

Profit Margin -616.5%

Employees 50

View Stock

Response Genetics, Inc

RGDXQ

Market Cap $3.87K

Dividends 0.0%

P/E Ratio 0.0

Revenue $3.79M

Net Income -$4.2M

Profit Margin -110.9%

Employees 96

View Stock